Your Health, We Care
Ibrutinib is also used to treat chronic lymphocytic leukemia/small lymphocytic lymphoma. Multiple international Phase II/III trials and Asia Pacific Phase III studies have evaluated the safety and efficacy of Ibrutinib in treating these diseases.
The results showed that Ibrutinib can significantly reduce the risk of death or progression in patients. Ibrutinib, as an important BTK inhibitor drug, has shown potential in the treatment of lymphoma.
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
